Zacks Investment Research on MSN
Why Merck's 32% rally isn't enough to change the bearish view
Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...
Year Merck Veteran and Former SVP of R&D IT Joins TetraScience to Help Industrialize Scientific Data and AI Across BiopharmaBOSTON, Jan. 15, 2026 /PRNewswire/ -- TetraScience, the Scientific ...
Merck Still Wants to "Grow Through Keytruda," Expects $70B in Revenue From New Programs by Mid-2030s
At the JP Morgan Healthcare Conference, the firm highlighted two antibody-drug conjugates among 10 programs that will fuel ...
Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the ...
As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...
Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...
The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.
American kids are no longer routinely being recommended shots against hepatitis A, meningitis, rotavirus and the flu.
Merck on Thursday said any changes to the U.S. child and adolescent immunization schedule should rest on comprehensive data ...
As 2025 comes to a close, we look back at the 10 most popular news stories on the Filtration+Separation website this year.
From structure confirmation to methodology improvements, making complex natural products has driven innovation in organic ...
A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results